epigallocatechin gallate has been researched along with Cystic Fibrosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kepp, O; Kroemer, G; Li, Y; Maiuri, L; Obrist, F; Pedro, JMBS; Sauvat, A; Sica, V; Stoll, G; Zamzami, N; Zhang, S | 1 |
| Amer, AO; Badr, A; Bundschuh, R; Caution, K; Chen, X; Cormet-Boyaka, E; Daily, K; Dakhlallah, D; Drew, ME; Estfanous, S; Frankhouser, DE; Gavrilin, MA; Gosu, H; Hamilton, K; Krause, K; Pan, A; Vaidya, A; Yan, P | 1 |
| Bona, G; Bossi, A; De Gregorio, F; De Rosa, G; De Stefano, D; Esposito, S; Grassia, R; Guido, S; Kroemer, G; Leone, CA; Maiuri, L; Maiuri, MC; Mehta, A; Pettoello-Mantovani, M; Pinna, LA; Raia, V; Salvadori, L; Sepe, A; Tosco, A; Venerando, A; Villella, VR; Zolin, A | 1 |
| Bona, G; Buonpensiero, P; De Gregorio, F; De Rosa, G; De Stefano, D; Di Pasqua, A; Esposito, S; Ferrari, E; Grassia, R; Guido, S; Kroemer, G; Leone, CA; Lusa, S; Maiuri, L; Maiuri, MC; Mehta, A; Raia, V; Salvadori, L; Sana, I; Sepe, A; Stoll, G; Tosco, A | 1 |
| Buer, J; Dittmer, S; Haase, G; Kirchhoff, L; Olsowski, M; Rath, PM; Sedlacek, L; Steinmann, E; Steinmann, J; Zilmans, K | 1 |
2 trial(s) available for epigallocatechin gallate and Cystic Fibrosis
| Article | Year |
|---|---|
Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.
Topics: Adaptor Proteins, Signal Transducing; Administration, Oral; Adolescent; Adult; Animals; Apoptosis Regulatory Proteins; Beclin-1; Catechin; Cell Membrane; Child; Chlorides; Cystamine; Cysteamine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Homozygote; Humans; Interleukin-8; Male; Membrane Proteins; Mice; Mice, Inbred CFTR; Mice, Transgenic; Mutation; Phenotype; Pilot Projects; Sequestosome-1 Protein; Tumor Necrosis Factor-alpha; Young Adult | 2014 |
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.
Topics: Adolescent; Animals; Autophagy; Biomarkers; Catechin; Child; Cysteamine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Drug Therapy, Combination; Homozygote; Humans; Interleukin-8; Lung; Mice; Mice, Knockout; Mutation; Sputum; Tumor Necrosis Factor-alpha | 2016 |
3 other study(ies) available for epigallocatechin gallate and Cystic Fibrosis
| Article | Year |
|---|---|
Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR.
Topics: Autophagy; Bronchi; Catechin; Cell Line; Cell Line, Tumor; Cysteamine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Transfection | 2018 |
Methylomic correlates of autophagy activity in cystic fibrosis.
Topics: Animals; Autophagy; Catechin; Cells, Cultured; Cystic Fibrosis; Macrophages; Mice; Mice, Inbred C57BL | 2019 |
Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.
Topics: Antifungal Agents; Bacterial Adhesion; beta-Glucans; Biofilms; Catechin; Colistin; Cystic Fibrosis; Echinocandins; Exophiala; Farnesol; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2017 |